EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Ocular Manifestations of Immune Reconstitution Inflammatory Syndrome in HIV after Highly Active Antiretroviral Therapy: Clinical Use of CD8+ T cell

Jae Hyun Kim, Myung Ho Cho, Ji Hoon Ban, Sun Hee Lee, Jong Soo Lee

Korean Journal of Ophthalmology · 2025

DOI: 10.3341/kjo.2024.0133 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Korean Journal of Ophthalmology, 2025. Verfasst von Jae Hyun Kim und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Pusan National University School of Medicine, Busan, Korea. Hauptthemen laut MEDLINE: Immune Reconstitution Inflammatory Syndrome, CD8-Positive T-Lymphocytes, Antiretroviral Therapy, Highly Active, HIV Infections. Die Arbeit nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Pusan National University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To investigate ocular manifestation of immune reconstitution inflammatory syndrome (IRIS) in HIV patients after starting highly active antiretroviral therapy (HAART) and its relationship to T cell immunity.

Methods

HIV patients with ocular IRIS after HAART were retrospectively reviewed. Clinical presentations with previous opportunistic infection, duration from initiation of HAART to IRIS, blood CD4+, CD8+ T cell count, and HIV RNA copies before HAART and at IRIS were analyzed.

Results

Among 19 patients (27 eyes) included, the most common previous opportunistic infection was cytomegalovirus (17 patients, 89.5%) followed by tuberculosis choroiditis (2 patients, 10.5%). The clinical manifestations included vitritis (20 eyes, 74.0%), retinitis (14 eyes, 51.9%), and anterior uveitis (5 eyes, 18.5%). The median duration from initiation of HAART to IRIS was 70 days. CD4+ T cell count before HAART increased at IRIS (p < 0.001). CD8+ T cell count before HAART was negatively correlated with duration from HAART to IRIS (p < 0.001). The cutoff value of CD8+ T cell count for discerning early or late onset of ocular IRIS was 258/mm3 (p = 0.001). When divided into two groups by CD8+ T cell count of 258/mm3, 90% patients with CD8+ T cell count higher than 258/mm3 before HAART developed ocular IRIS within 70 days.

Conclusions

There was a negative relationship between CD8+ T cell count before HAART and duration from HAART to ocular IRIS. Ocular IRIS with higher CD8+ T cell count before HAART developed earlier after HAART initiation compared to those with lower CD8+ T cell count.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Immune Reconstitution Inflammatory SyndromeCD8-Positive T-LymphocytesAntiretroviral Therapy, Highly ActiveHIV InfectionsHumansMaleRetrospective StudiesFemaleAdultMiddle AgedFollow-Up StudiesCD4 Lymphocyte Count

Stichwörter der Autor:innen

CD8+ T cellCytomegalovirus retinitisHIVImmune reconstitution inflammatory syndrome

Autor:innen und Institutionen

  • Department of Ophthalmology, Pusan National University School of Medicine, Busan, Korea.
  • Department of Internal Medicine, Pusan National University School of Medicine, Busan, Korea.
  • Biomedical Research Institute, Pusan National University Hospital, Busan, Korea.

Förderung

  • Pusan National University

Zitieren

APA

Kim, J. H., Cho, M. H., Ban, J. H., Lee, S. H., & Lee, J. S. (2025). Ocular Manifestations of Immune Reconstitution Inflammatory Syndrome in HIV after Highly Active Antiretroviral Therapy: Clinical Use of CD8+ T cell. Korean Journal of Ophthalmology. https://doi.org/10.3341/kjo.2024.0133

Vancouver

Kim JH, Cho MH, Ban JH, Lee SH, Lee JS. Ocular Manifestations of Immune Reconstitution Inflammatory Syndrome in HIV after Highly Active Antiretroviral Therapy: Clinical Use of CD8+ T cell. Korean Journal of Ophthalmology. 2025. doi:10.3341/kjo.2024.0133

BibTeX
@article{Kim2025,
  author = {Kim, Jae Hyun and Cho, Myung Ho and Ban, Ji Hoon and Lee, Sun Hee and Lee, Jong Soo},
  title = {Ocular Manifestations of Immune Reconstitution Inflammatory Syndrome in HIV after Highly Active Antiretroviral Therapy: Clinical Use of CD8+ T cell},
  journal = {Korean Journal of Ophthalmology},
  year = {2025},
  doi = {10.3341/kjo.2024.0133}
}
Kostenlos starten →